Aim of the Study: Treatment protocols that use intravenous cytotoxic agents need long term access to large veins, that can be maintained for a prolonged period in a sterile way. Use of implantable devices for this purpose have become the preferred choice these days, but they have...
Open access
Research Article10.9734/JCTI/2018/42732
Objective: In India, 75,000 new cases of lung cancer are diagnosed every year, with approximately 35% of them being locally advanced at presentation. Despite numerous advances in recent years in terms of diagnostic methods, molecular changes, and therapeutic interventions, the ou...
Open access
Research Article10.9734/JCTI/2018/42159
Background: Hepatitis C virus (HCV) is a hepatotropic and potentially lymphotropic virus. Chronic HCV infection might be involved in the pathogenesis of non-Hodgkin’s lymphoma (NHL). Aim: to determine the prevalence of HCV infection in patients with NHL and its effect on treatmen...
Open access
Research Article10.9734/JCTI/2018/40087
Background: Paragangliomas are rare asymptomatic painless tumours, originating from paraganglionic bodies of autonomous nerve system. The carotid body tumours are the relatively rare tumour but constitute a majority of head and neck paragangliomas about 70%. These tumours are ben...
Open access
Research Article10.9734/JCTI/2018/40034
Introduction: Poorly differentiated thyroid carcinoma (PDTC) is a rare malignancy which accounts for only 1 to 15% of all thyroid cancers. There is only limited literature on PDTC regarding its clinical behavior and treatment consensus, and there was no published data from south...
Open access
Research Article10.9734/JCTI/2018/40857
Background: Incidence of pancreatic cancer is relatively low compared to other types of cancer but had the lowest survival rate of all cancers. Objective: To describe clinical-epidemiological features of pancreatic cancer patients recorded in our region and assessed its different...
Open access
Research Article10.9734/JCTI/2018/31933
Lymphoblastic lymphomas (LBL) are malignant proliferations of the lymphoid precursors of T cells mainly. LBL accounts for approximately 2% of all non-Hodgkin’s lymphomas in the developed countries. Until the 1970s, diffuse lymphoblastic lymphoma was considered incurable. With int...
Open access
Research Article10.9734/JCTI/2018/39914
Traoré Fousseyni, Togo Boubacar, Diakité Abdoul Aziz, Maiga Belco, Diall Hawa, Issa Amadou, Diabaté Konimba, Sacko Karamoko, Dicko- Traoré Fatoumata & Sylla Mariam·Journal of Cancer and Tumor International·2018
Anaplastic large cell lymphoma is a rare malignancy during childhood. Equally rare are publications of the disease in African children. We reported two cases which successfully treated by chemotherapy in the pediatric oncology unit at Gabriel Touré Hospital in Bamako, Mali. The...
Open access
Research Article10.9734/JCTI/2018/39915
Primary central nervous system lymphoma (PCNSL) is a very rare and aggressive form of B-cell non- Hodgkin’s lymphoma. It originates but is restricted to the central nervous system (CNS) at the time of diagnosis. Patients typically present with focal neurologic deficits, cranial n...
Open access
Research Article10.9734/JCTI/2018/39853
Aims: Inhibition of ultraviolet-A and -B (UVA+B) skin tumour formation by topical treatment with non-steroidal anti-inflammatory drugs (NSAIDs) was investigated in SKH-1 hairless mice. Methodology: A UV skin tumour study was designed. Group of mice were irradiated with daily dose...
Open access
Research Article10.9734/JCTI/2018/39590